Select Publications

Journal articles

Mirzazadeh A; Salimzadeh H; Arabi M; Hajarizadeh B; Navadeh S; Haghdoost AA, 2013, 'Trends of obesity in Iranian adults from 1990s to late 2000s; a Systematic Review and Meta-analysis', Middle East Journal of Digestive Diseases, 5, pp. 151 - 157, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990178/

Hajarizadeh B; Grebely J, 2012, 'HIV and Liver Disease', PRACTICAL GASTROENTEROLOGY, 36, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000421778800005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wallace J; McNally S; Richmond J; Hajarizadeh B; Pitts M, 2012, 'Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia', Sexual Health, 9, pp. 131 - 137, http://dx.doi.org/10.1071/SH10137

Hajarizadeh B; Grebely J; Dore GJ, 2012, 'Case definitions for acute hepatitis C virus infection: A systematic review', Journal of Hepatology, 57, pp. 1349 - 1360, http://dx.doi.org/10.1016/j.jhep.2012.07.007

Wallace J; Hajarizadeh B; Richmond J; McNally S; Pitts M, 2012, 'Managing chronic hepatitis B The role of the GP', Australian Family Physician, 41, pp. 893 - 898, http://search.informit.com.au/fullText;dn=896906313252806;res=IELHEA

Wallace J; McNally S; Richmond J; Hajarizadeh B; Pitts M, 2011, 'Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia', BMC Research Notes, 4, http://dx.doi.org/10.1186/1756-0500-4-45

Shariat-Torbaghan S; Emami-Aleagha M; Sedighi S; Azadbakht F; Keshvari A; Hajarizadeh B; Rosai J, 2009, 'Squamous cell carcinoma arising in an ovarian mature cystic teratoma: A case report', Archives of Iranian Medicine, 12, pp. 186 - 189

Hajarizadeh B; Rashidian A; Haghdoost AA; Alavian SM, 2009, 'COMPARING COST-EFFECTIVENESS OF THE THREE-VERSUS TWO-DOSE VACCINATION PROTOCOL AGAINST HEPATITIS B IN ADOLESCENTS', VALUE IN HEALTH, 12, pp. A112 - A112, http://dx.doi.org/10.1016/S1098-3015(10)73623-8

Hajarizadeh B; Rashidian A; Haghdoost AA; Alavian SM, 2009, 'COST ANALYSIS OF THE MASS VACCINATION CAMPAIGN AGAINST HEPATITIS B IN ADOLESCENTS IN IRAN', VALUE IN HEALTH, 12, pp. A114 - A114, http://dx.doi.org/10.1016/S1098-3015(10)73635-4

Movahedi M; Hajarizadeh B; Rahimi A; Arshinchi M; Amirhosseini K; Haghdoost AA, 2009, 'Trends and geographical inequalities of the main health indicators for rural Iran', Health Policy and Planning, 24, pp. 229 - 237, http://dx.doi.org/10.1093/heapol/czp007

Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B, 2009, 'Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures', Liver International, 29, pp. 159 - 163, http://dx.doi.org/10.1111/j.1478-3231.2008.01790.x

Alavian SM; Gooya MM; Hajarizadeh B; Esteghamati AR; Moeinzadeh AM; Haghazali M; Zamani GA; Yaghini F; Lankarani KB, 2009, 'Mass vaccination campaign against hepatitis B in adolescents in Iran: Estimating coverage using administrative data', Hepatitis Monthly, 9, pp. 189 - 195

Tavallaii SA; Mirzamani M; Heshmatzade Behzadi A; Assari S; Khoddami Vishteh HR; Hajarizadeh B; Einollahi B, 2009, 'Sexual function: A comparison between male renal transplant recipients and hemodialysis patients', Journal of Sexual Medicine, 6, pp. 142 - 148, http://dx.doi.org/10.1111/j.1743-6109.2008.01047.x

Movahedi M; Haghdoost AA; Pournik O; Hajarizadeh B; Fallah MS, 2008, 'Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades', Journal of Public Health, 30, pp. 499 - 504, http://dx.doi.org/10.1093/pubmed/fdn071

Sali S; Alavian SM; Hajarizadeh B, 2008, 'Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients', Nephrology, 13, pp. 376 - 379, http://dx.doi.org/10.1111/j.1440-1797.2008.00952.x

Alavian SM; Hajarizadeh B; Ahmadzad-Asl M; Kabir A; Bagheri-Lankarani K, 2008, 'Hepatitis B virus infection in Iran: A systematic review', Hepatitis Monthly, 8, pp. 281 - 294

Haghdoost AA; Sadeghirad B; Hajarizadeh B; Mirzazadeh A, 2007, 'The application of Systematic Review and Meta-analysis concepts in summarizing the findings of observational studies', Iranian Journal of Psychiatry, 2, pp. 132 - 136, http://ijps.tums.ac.ir/index.php/ijps/article/view/453

Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MMA; Faridi AR; Davari K; Hajibeigi B, 2006, 'Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study', Archives of Iranian Medicine, 9, pp. 319 - 323

Jahani MR; Alavian SM; Shirzad H; Kabir A; Hajarizadeh B, 2005, 'Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour" [9]', Sexually Transmitted Infections, 81, pp. 185, http://dx.doi.org/10.1136/sti.2004.011114

Hajarizadeh B; Alavian S, 2005, 'Clinical features of coinfection with TTV in hepatitis C virus–infected patients undergoing hemodialysis', American Journal of Infection Control, 33, pp. e95 - e95, http://dx.doi.org/10.1016/j.ajic.2005.04.115

Hajarizadeh B; Alavian S; Jahani M, 2005, 'Distribution and risk factors of hepatitis b (HBV), hepatitis c (HBC), and HIV infection in a female population with illegal social behavior', American Journal of Infection Control, 33, pp. e97 - e98, http://dx.doi.org/10.1016/j.ajic.2005.04.119

Hajarizadeh B; Alavian S, 2005, 'Efficacy and safety of pegylated interferon alpha-2a (40 KD) plus ribavirin for treatment of chronic hepatitis C and cirrhosis in Iranian patients', American Journal of Infection Control, 33, pp. e97 - e97, http://dx.doi.org/10.1016/j.ajic.2005.04.118

Hajarizadeh B; Mirjalili A; Mohraz M, 2005, 'Epidemiology of Mycobacterium tuberculosis infection among Iranian HIV–infected patients', American Journal of Infection Control, 33, pp. e98 - e98, http://dx.doi.org/10.1016/j.ajic.2005.04.120

Hajarizadeh B; Alavian S; Mirmomen S, 2005, 'Hepatitis B and C among thalassemiac patients in Iran: A multicenter study', American Journal of Infection Control, 33, pp. e94 - e94, http://dx.doi.org/10.1016/j.ajic.2005.04.114

Hajarizadeh B; Einollahi B; Alavian S; Nafar M, 2005, 'Prevalence of Hepatitis c virus (HCV) infection and related risk factors among Iranian patients on hemodialysis', American Journal of Infection Control, 33, pp. e93 - e94, http://dx.doi.org/10.1016/j.ajic.2005.04.113

Alavian SM; Hajarizadeh B; Nematizadeh F; Larijini B, 2004, 'Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease', BMC Endocrine Disorders, 4, http://dx.doi.org/10.1186/1472-6823-4-4

Alavian SM; Hajarizadeh B, 2004, 'Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs [7]', Gut, 53, pp. 1057

Alavian SM; Hajarizadeh B, 2004, 'Attempted suicide in two patients with chronic hepatitis C while being treated with Interferon-alpha', Hepatitis Monthly, 4, pp. 20 - 22, http://hepatmon.portal.tools/?page=article&article_id=691

Alavian SM; Kabir A; Hajarizadeh B; Nayebpour M; Haji Beigi B; Doroudi T; Baralle F, 2004, 'Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C', Hepatitis Monthly, 4, pp. 13 - 16, http://hepatmon.portal.tools/?page=article&article_id=689

Alavian SM; Hajarizadeh B; Hajibeigi B; Doroudi T; Hamedianizadeh AK; Abar K, 2004, 'Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranians', Hepatitis Monthly, 4, pp. 53 - 58, http://hepatmon.portal.tools/?page=article&article_id=668

Alavian SM; Einollahi B; Hajarizadeh B; Bakhtiari S; Nafar M; Ahrabi S, 2003, 'Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients', Nephrology, 8, pp. 256 - 260, http://dx.doi.org/10.1046/j.1440-1797.2003.00166.x

Einollahi B; Hajarizadeh B; Bakhtiari S; Lesanpezeshki M; Khatami MR; Nourbala MH; Pourfarziani V; Alavian SM, 2003, 'Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients', Journal of Gastroenterology and Hepatology (Australia), 18, pp. 836 - 840, http://dx.doi.org/10.1046/j.1440-1746.2003.03063.x

Alavian SM; Hajarizadeh B; Einollahi B, 2003, 'Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients', Transplantation Proceedings, 35, pp. 2687 - 2688, http://dx.doi.org/10.1016/j.transproceed.2003.08.042

Simforoosh N; Basiri A; Pourrezagholi F; Einolahi B; Firouzan A; Moghaddam MM; Nourbala MH; Hajarizadeh B; Pourfarziani V; Lessanpezeshki M; Nafar M; Khatami MR; Moghaddam SMMH; Farhangi S, 2003, 'Is preemptive renal transplantation preferred?', Transplantation Proceedings, 35, pp. 2598 - 2601, http://dx.doi.org/10.1016/j.transproceed.2003.09.026

Einollahi B; Hajarizadeh B; Simforoosh N; Lessanpezeshki M; Khatami MR; Nourbala MH; Basiri A; Pourfarziani V; Firoozan A; Nafar M; Poorrezagholi F; Sharifian M; Bakhtiari S; Alavian SM, 2003, 'Patient and graft outcome after living donor renal transplantation in Iran: More than 15-year follow-up', Transplantation Proceedings, 35, pp. 2605 - 2606, http://dx.doi.org/10.1016/j.transproceed.2003.09.075

Conference Papers

Hajarizadeh B, 2019, 'HEPATITIS C TREATMENT, REINFECTION AND ELIMINATION AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Artenie AA; Cunningham E; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Applegate TL; Dillon JF; Fraser C; Gane E; Litwin AH; Marks P; Matthews GV; Quiene S; Thurnheer MC; Weltman M; Dore G; Bruneau J; Grebely J, 2018, 'Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 31 - 32, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S187 - S188, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0

Cunningham EB; Hajarizadeh B; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Dore GJ; Lloyd AR; Grebely J, 2017, 'Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005-2014: the HITS-p study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S488 - S488, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31370-3

Lamoury F; Hajarizadeh B; Martinello M; Soker A; Martinez D; Cunningham P; Cloherty GA; Marks P; Matthews G; Amin J; Grebely J; Dore G; Applegate TL, 2016, 'Hepatitis C virus core antigen: A simplified treatment monitoring tool among those with recent Hepatitis C virus infection, including for post-treatment relapse', in HEPATOLOGY, WILEY, MA, Boston, pp. 415A - 415A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grebely J; Byrne M; Marks P; Butler T; Amin J; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore G, 2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', in HEPATOLOGY, WILEY, MA, Boston, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cunningham EB; Luciani F; Hajarizadeh B; Betz-Stablein B; Bretana NA; Teutsch S; Dore GJ; Grebely J; Lloyd AR, 2016, 'STABLE INCIDENCE OF HEPATITIS C VIRUS INFECTION AMONG PEOPLE WITH A HISTORY OF INJECTING DRUG USE IN AN AUSTRALIAN PRISON SETTING, 2005-2014: THE HITS-P STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S614 - S614, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)01138-7

Waziry RK; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews G; Law M; Dore G, 2015, 'Trends in end-stage liver disease among people notified with HBV or HCV in New South Wales, Australia: 2000-2014', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1121A - 1121A, presented at 66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 13 November 2015 - 17 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368375404114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady B; Page K; Kim AY; Mcgovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J, 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: The InC3 study', in Journal of Viral Hepatitis, Blackwell Publishing Ltd, http://dx.doi.org/10.1111/jvh.12384

Sheridan DA; Hajarizadeh B; Matthews G; Applegate TL; Douglas MW; Askew B; Neely D; Bassendine MF; Dore GJ; Lloyd AR; George J; Grebely J, 2014, 'Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 929A - 929A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD; Amin J; Schinkel J; Applegate TL; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Grady B; Schinkel J; Maher L; Hellard M; Lloyd AR; Prins M; Grebely J; Dore GJ, 2013, 'EARLY HCVRNA DYNAMICS AND FACTORS ASSOCIATED WITH HIGH EARLY HCVRNA LEVEL DURING ACUTE HCV INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S470 - S471, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)61158-7


Back to profile page